Influenza Vaccine (Split Virion), lnactivated – Anflu^®

Pandemic Influenza Vaccine, lnactivated, Adjuvanted – Panflu^®

H1N1 Influenza A Vaccine (Split Virion), lnactivated – Panflu.1^®

Influenza Vaccine (Split Virion), lnactivated, Quadrivalent – TetrAnflu^®

• Anflu^®, preservative-free trivalent influenza vaccine, was launched in 2006.

• Panflu^®, H5N1 flu vaccine, is the first of its kind in China and was approved for national stockpiling in 2008.

• Panfu.1^®, world's first H1N1 influenza A vaccine, was approved in 2009 and is used for massive inoculation around the world.

• TetrAnflu^®, quadrivalent influenza vaccine, was launched in 2020:

• Provides complete coverage against all four types of influenza viruses and corresponding strains.

• Demonstrates a low occurrence of adverse reactions and excellent safety.

• Serum protection rates for each type are greater than 90%, which exceeds EU standards.